Nintedanib in patients with progressive fibrosing ILDs in subgroups by comorbidity burden

被引：0
|
作者：
Bendstrup, E. [1 ]
Moua, T. [2 ]
Okamoto, M. [3 ]
Tomassetti, S. [4 ]
Valenzuela, C. [5 ]
Wuyts, A. [6 ]
Miede, C. [7 ]
Lievens, D. [8 ]
Bonella, F. [9 ]
机构：
[1] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Ctr Rare Lung Dis, Aarhus, Denmark
[2] Mayo Clin Rochester, Div Pulm & Crit Care Med, Rochester, MN USA
[3] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka, Japan
[4] Careggi Univ Hosp, Dept Expt & Clin Med, Florence, Italy
[5] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain
[6] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[7] Mainanalytics GmbH, Sulzbach, Taunus, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Univ Duisburg Essen, Pneumol Dept, Ctr Interstitial & Rare Lung Dis, Ruhrlandklin, Essen, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.615
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nintedanib in children and adolescents with fibrosing ILDs: interim analysis of InPedILDON
    Deterding, Robin
    Young, Lisa
    Deboer, Emily
    Warburton, David
    Cunningham, Steven
    Schwerk, Nicolaus
    Brown, Kevin
    Koucky, Vaclav
    Weinman, Jason P.
    Simmons, Jill
    Dumistracel, Mihaela
    Jantzen, Frauke
    Gahlemann, Martina
    Griese, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [22] Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by GAP Stage
    Ryerson, C. J.
    Chaudhuri, N.
    Perez, E. R. Fernandez
    Kim, Y.
    Silva, R. S.
    Wuyts, W. A.
    Mueller, H.
    Rohr, K. B.
    Kolb, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [23] Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis
    Strek, M. E.
    Hallowell, R. W.
    Kus, J.
    Nunes, H.
    Suda, T.
    Tomassetti, S.
    Mueller, H.
    Rohr, K. B.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Characteristics of patients with progressive fibrosing ILDs in the ILD-PRO Registry
    Lobo, Leonard
    Liu, Yi
    Li, Peide
    Ramaswamy, Murali
    Swaminathan, Aparna C.
    Veeraraghavan, Srihari
    Fan, Yanni
    Neely, Megan L.
    Palmer, Scott M.
    Olson, Amy L.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] Effect of nintedanib on decline in forced vital capacity (FVC) in patients with progressive fibrosing interstitial lung diseases (ILDs) by time since diagnosis
    Skowasch, D.
    Strek, M.
    Hallowell, W. R.
    Kus, J.
    Nunes, H.
    Suda, T.
    Tomassetti, S.
    Mueller, H.
    Rohr, B. K.
    Flaherty, R. K.
    PNEUMOLOGIE, 2022, 76 : S22 - S22
  • [26] Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
    Joannes, Audrey
    Voisin, Tom
    Morzadec, Claudie
    Letellier, Alice
    Gutierrez, Francisco Llamas
    Chiforeanu, Dan Cristian
    Le Naoures, Cecile
    Guillot, Stephanie
    De Latour, Bertrand Richard
    Rouze, Simon
    Jaillet, Madeleine
    Crestani, Bruno
    Wollin, Lutz
    Jouneau, Stephanie
    Vernhet, Laurent
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [27] Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs): Data from INBUILD-ON
    Matteson, Eric
    Antin-Ozerkis, Danielle
    Bonella, Francesco
    Chaudhuri, Nazia
    Cottin, Vincent
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus
    Wuyts, Wim
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 260 - 262
  • [28] Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib
    Matteson, Eric
    Distler, Oliver
    Distler, Joerg H. W.
    Kuwana, Masataka
    Pope, Janet
    Seibold, James
    James, Alexandra
    Schlenker-Herceg, Rozsa
    Rohr, Klaus
    Flaherty, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [29] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Fabre, Aurelie
    Nicholson, Andrew G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 780
  • [30] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
12345